

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 6.45266111 |
| 2 | response to muscle activity (GO:0014850) | 6.30555979 |
| 3 | actin-myosin filament sliding (GO:0033275) | 6.08319622 |
| 4 | muscle filament sliding (GO:0030049) | 6.08319622 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 5.86538091 |
| 6 | skeletal muscle fiber development (GO:0048741) | 5.64091917 |
| 7 | NADH metabolic process (GO:0006734) | 5.27815032 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.20345358 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.20345358 |
| 10 | response to inactivity (GO:0014854) | 5.18441675 |
| 11 | carnitine shuttle (GO:0006853) | 5.17492038 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.11058913 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.11058913 |
| 14 | myotube cell development (GO:0014904) | 5.10634824 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 5.02251211 |
| 16 | actin-mediated cell contraction (GO:0070252) | 4.96806448 |
| 17 | muscle contraction (GO:0006936) | 4.84791093 |
| 18 | lysine metabolic process (GO:0006553) | 4.83483725 |
| 19 | lysine catabolic process (GO:0006554) | 4.83483725 |
| 20 | fructose metabolic process (GO:0006000) | 4.83366388 |
| 21 | skeletal muscle contraction (GO:0003009) | 4.82590172 |
| 22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.80493413 |
| 23 | sarcomere organization (GO:0045214) | 4.72183408 |
| 24 | kynurenine metabolic process (GO:0070189) | 4.70579587 |
| 25 | 2-oxoglutarate metabolic process (GO:0006103) | 4.68782214 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 4.59270008 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.56737222 |
| 28 | glyoxylate metabolic process (GO:0046487) | 4.55744326 |
| 29 | drug catabolic process (GO:0042737) | 4.46874252 |
| 30 | cardiac muscle contraction (GO:0060048) | 4.43052791 |
| 31 | actomyosin structure organization (GO:0031032) | 4.39995948 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35993314 |
| 33 | exogenous drug catabolic process (GO:0042738) | 4.32091584 |
| 34 | muscle system process (GO:0003012) | 4.31717863 |
| 35 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.27395120 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 4.23231315 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.20612142 |
| 38 | aspartate family amino acid catabolic process (GO:0009068) | 4.20057245 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 4.15631573 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 4.15631573 |
| 41 | tryptophan catabolic process (GO:0006569) | 4.15631573 |
| 42 | glycogen catabolic process (GO:0005980) | 4.14925411 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.11052346 |
| 44 | gluconeogenesis (GO:0006094) | 4.10418992 |
| 45 | bile acid biosynthetic process (GO:0006699) | 4.08201337 |
| 46 | tricarboxylic acid cycle (GO:0006099) | 4.07258672 |
| 47 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.05459190 |
| 48 | fatty acid beta-oxidation (GO:0006635) | 4.04045557 |
| 49 | myofibril assembly (GO:0030239) | 4.02777194 |
| 50 | muscle fiber development (GO:0048747) | 4.01419183 |
| 51 | plasma membrane repair (GO:0001778) | 4.01241306 |
| 52 | epoxygenase P450 pathway (GO:0019373) | 3.99894378 |
| 53 | regulation of cell communication by electrical coupling (GO:0010649) | 3.98868070 |
| 54 | skeletal muscle adaptation (GO:0043501) | 3.98476105 |
| 55 | regulation of actin filament-based movement (GO:1903115) | 3.94471662 |
| 56 | creatine metabolic process (GO:0006600) | 3.93522353 |
| 57 | acetyl-CoA metabolic process (GO:0006084) | 3.93508152 |
| 58 | glucan catabolic process (GO:0009251) | 3.93420103 |
| 59 | carnitine transmembrane transport (GO:1902603) | 3.92946734 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 3.91384347 |
| 61 | skeletal muscle tissue development (GO:0007519) | 3.91127296 |
| 62 | tryptophan metabolic process (GO:0006568) | 3.89107334 |
| 63 | cardiac muscle hypertrophy (GO:0003300) | 3.86471831 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.84167104 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.83192464 |
| 66 | striated muscle adaptation (GO:0014888) | 3.82774123 |
| 67 | response to mercury ion (GO:0046689) | 3.79658619 |
| 68 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.74672612 |
| 69 | hexose biosynthetic process (GO:0019319) | 3.74625372 |
| 70 | skeletal muscle tissue regeneration (GO:0043403) | 3.74620160 |
| 71 | regulation of sequestering of triglyceride (GO:0010889) | 3.71302651 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.71020204 |
| 73 | carnitine transport (GO:0015879) | 3.71020204 |
| 74 | glycogen metabolic process (GO:0005977) | 3.70926682 |
| 75 | regulation of protein activation cascade (GO:2000257) | 3.70924113 |
| 76 | fatty acid oxidation (GO:0019395) | 3.70421399 |
| 77 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70045669 |
| 78 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.69806991 |
| 79 | serine family amino acid catabolic process (GO:0009071) | 3.69473325 |
| 80 | actin filament-based movement (GO:0030048) | 3.69305744 |
| 81 | sulfur amino acid catabolic process (GO:0000098) | 3.69025611 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.68934176 |
| 83 | fatty acid catabolic process (GO:0009062) | 3.68788017 |
| 84 | regulation of fibrinolysis (GO:0051917) | 3.68635316 |
| 85 | striated muscle hypertrophy (GO:0014897) | 3.67800408 |
| 86 | cellular polysaccharide catabolic process (GO:0044247) | 3.67578631 |
| 87 | striated muscle contraction (GO:0006941) | 3.66006528 |
| 88 | high-density lipoprotein particle remodeling (GO:0034375) | 3.65684750 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.65282647 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.64806461 |
| 91 | protein carboxylation (GO:0018214) | 3.64806461 |
| 92 | alpha-amino acid catabolic process (GO:1901606) | 3.64551243 |
| 93 | cysteine metabolic process (GO:0006534) | 3.64050866 |
| 94 | glucan metabolic process (GO:0044042) | 3.63306404 |
| 95 | cellular glucan metabolic process (GO:0006073) | 3.63306404 |
| 96 | lipid oxidation (GO:0034440) | 3.63186943 |
| 97 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.62447906 |
| 98 | urea cycle (GO:0000050) | 3.62201041 |
| 99 | urea metabolic process (GO:0019627) | 3.62201041 |
| 100 | ketone body metabolic process (GO:1902224) | 3.61958462 |
| 101 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54950340 |
| 102 | valine metabolic process (GO:0006573) | 3.54818098 |
| 103 | muscle cell cellular homeostasis (GO:0046716) | 3.54810175 |
| 104 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.54280161 |
| 105 | monocarboxylic acid catabolic process (GO:0072329) | 3.52334558 |
| 106 | ethanol oxidation (GO:0006069) | 3.49311888 |
| 107 | acylglycerol homeostasis (GO:0055090) | 3.48602319 |
| 108 | triglyceride homeostasis (GO:0070328) | 3.48602319 |
| 109 | coenzyme catabolic process (GO:0009109) | 3.47365520 |
| 110 | regulation of complement activation (GO:0030449) | 3.46920113 |
| 111 | polysaccharide catabolic process (GO:0000272) | 3.46367015 |
| 112 | omega-hydroxylase P450 pathway (GO:0097267) | 3.46362941 |
| 113 | branched-chain amino acid catabolic process (GO:0009083) | 3.45066658 |
| 114 | homocysteine metabolic process (GO:0050667) | 3.41907261 |
| 115 | carnitine metabolic process (GO:0009437) | 3.41650723 |
| 116 | cardiac myofibril assembly (GO:0055003) | 3.41545965 |
| 117 | glucan biosynthetic process (GO:0009250) | 3.40302112 |
| 118 | glycogen biosynthetic process (GO:0005978) | 3.40302112 |
| 119 | muscle cell fate commitment (GO:0042693) | 3.39062676 |
| 120 | cellular amino acid catabolic process (GO:0009063) | 3.38766105 |
| 121 | bile acid metabolic process (GO:0008206) | 3.38139842 |
| 122 | oxaloacetate metabolic process (GO:0006107) | 3.37993506 |
| 123 | oxidative demethylation (GO:0070989) | 3.36614988 |
| 124 | nitrogen cycle metabolic process (GO:0071941) | 3.36231754 |
| 125 | response to activity (GO:0014823) | 3.33177323 |
| 126 | positive regulation of myotube differentiation (GO:0010831) | 3.33141396 |
| 127 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.32890320 |
| 128 | muscle hypertrophy (GO:0014896) | 3.30738719 |
| 129 | aromatic amino acid family metabolic process (GO:0009072) | 3.30429284 |
| 130 | striated muscle atrophy (GO:0014891) | 3.30327010 |
| 131 | positive regulation of fatty acid oxidation (GO:0046321) | 3.30221066 |
| 132 | regulation of fatty acid oxidation (GO:0046320) | 3.30121519 |
| 133 | succinate metabolic process (GO:0006105) | 3.29648038 |
| 134 | monosaccharide biosynthetic process (GO:0046364) | 3.28853734 |
| 135 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.28771895 |
| 136 | phospholipid homeostasis (GO:0055091) | 3.26938961 |
| 137 | blood coagulation, intrinsic pathway (GO:0007597) | 3.25235500 |
| 138 | organic acid catabolic process (GO:0016054) | 3.24109583 |
| 139 | carboxylic acid catabolic process (GO:0046395) | 3.24109583 |
| 140 | glutamate metabolic process (GO:0006536) | 3.23879750 |
| 141 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.21510063 |
| 142 | regulation of striated muscle contraction (GO:0006942) | 3.17535129 |
| 143 | muscle tissue morphogenesis (GO:0060415) | 3.15583023 |
| 144 | muscle organ development (GO:0007517) | 3.12489822 |
| 145 | muscle structure development (GO:0061061) | 3.11919963 |
| 146 | muscle organ morphogenesis (GO:0048644) | 3.11236054 |
| 147 | striated muscle cell development (GO:0055002) | 3.09174562 |
| 148 | muscle adaptation (GO:0043500) | 3.06837839 |
| 149 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.02377285 |
| 150 | cellular carbohydrate catabolic process (GO:0044275) | 3.01571607 |
| 151 | muscle atrophy (GO:0014889) | 3.00857503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.57221389 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.54735999 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.51728369 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.88603283 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24338393 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.45210271 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.30127264 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76817108 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.49118500 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.34221498 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00654696 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.63122742 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48704538 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.17028857 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05138391 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.99938597 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99921409 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99444247 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94268438 |
| 20 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.89553399 |
| 21 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.89553399 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86797495 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84359854 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76659663 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74690849 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.54165405 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51314430 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51138934 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47362603 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46311820 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42847178 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.38911603 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32159885 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27500766 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25458657 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24333037 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21413002 |
| 38 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.19208066 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16216584 |
| 40 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10872883 |
| 41 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09925242 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08521665 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07146103 |
| 44 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06796559 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06656749 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06159034 |
| 47 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05297846 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05111328 |
| 49 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04942865 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00040834 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99973331 |
| 52 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99880508 |
| 53 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99740775 |
| 54 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99466463 |
| 55 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99064792 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98104302 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97332971 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95644395 |
| 59 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95411948 |
| 60 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95205233 |
| 61 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94534960 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90038115 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89510774 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87659057 |
| 65 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.87129616 |
| 66 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.86660803 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85972867 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85371227 |
| 69 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84174787 |
| 70 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.83600552 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82814862 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82195243 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81378246 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80415994 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80415994 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80178505 |
| 77 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79832958 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78727111 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.78382577 |
| 80 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.77950878 |
| 81 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77879556 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76218284 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.75789213 |
| 84 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.75128455 |
| 85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75114665 |
| 86 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.74962008 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71852744 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.71401273 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71001021 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70832174 |
| 91 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.70797259 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.69081960 |
| 93 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.68628934 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68602528 |
| 95 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.68419136 |
| 96 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.68331864 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.68124035 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68025636 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67791734 |
| 100 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.66749124 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.66600510 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.65517330 |
| 103 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.65461659 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64446171 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63746774 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.63733418 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.63186362 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.63049156 |
| 109 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.61645326 |
| 110 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.61476752 |
| 111 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.61086117 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60676784 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.60513119 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60399875 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.59460696 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 0.59390157 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.58910985 |
| 118 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58880587 |
| 119 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.58390527 |
| 120 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.58073633 |
| 121 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.57919122 |
| 122 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.57549891 |
| 123 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56898651 |
| 124 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.56893790 |
| 125 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.56452824 |
| 126 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.55444944 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.55421775 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54801943 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54262619 |
| 130 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.53758359 |
| 131 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.53713653 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.53649840 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.53360879 |
| 134 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.53239864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.01427110 |
| 2 | MP0003646_muscle_fatigue | 4.81473086 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.36660440 |
| 4 | MP0005360_urolithiasis | 4.28659504 |
| 5 | MP0000751_myopathy | 4.06796926 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 4.05717365 |
| 7 | MP0000749_muscle_degeneration | 4.01967642 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.82653814 |
| 9 | MP0005365_abnormal_bile_salt | 3.62818450 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.42835185 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.16306592 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.90426958 |
| 13 | MP0004130_abnormal_muscle_cell | 2.83298623 |
| 14 | MP0000747_muscle_weakness | 2.63035969 |
| 15 | MP0002269_muscular_atrophy | 2.54644476 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.52507415 |
| 17 | MP0002106_abnormal_muscle_physiology | 2.52197751 |
| 18 | MP0004084_abnormal_cardiac_muscle | 2.49455419 |
| 19 | MP0003252_abnormal_bile_duct | 2.46688112 |
| 20 | MP0005330_cardiomyopathy | 2.35417780 |
| 21 | MP0005083_abnormal_biliary_tract | 2.26501818 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.23413650 |
| 23 | MP0005620_abnormal_muscle_contractility | 2.20559280 |
| 24 | MP0000759_abnormal_skeletal_muscle | 2.20015445 |
| 25 | MP0009840_abnormal_foam_cell | 2.19712131 |
| 26 | MP0000750_abnormal_muscle_regeneration | 2.16099284 |
| 27 | MP0004215_abnormal_myocardial_fiber | 2.11505080 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 2.08075003 |
| 29 | MP0005369_muscle_phenotype | 2.06093361 |
| 30 | MP0003195_calcinosis | 2.02299257 |
| 31 | MP0005332_abnormal_amino_acid | 1.77072566 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.56475432 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.54654329 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.52533684 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.51039155 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.47831024 |
| 37 | MP0004233_abnormal_muscle_weight | 1.43326412 |
| 38 | MP0010630_abnormal_cardiac_muscle | 1.41455056 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.39444644 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.38155233 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.36197595 |
| 42 | * MP0000609_abnormal_liver_physiology | 1.34353782 |
| 43 | MP0005385_cardiovascular_system_phenoty | 1.33623167 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.33623167 |
| 45 | MP0001661_extended_life_span | 1.33123552 |
| 46 | MP0002971_abnormal_brown_adipose | 1.30754447 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.26321380 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.25114319 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25107396 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.23982143 |
| 51 | MP0003137_abnormal_impulse_conducting | 1.23077772 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.21693785 |
| 53 | MP0004484_altered_response_of | 1.21110536 |
| 54 | MP0005266_abnormal_metabolism | 1.20865180 |
| 55 | MP0004270_analgesia | 1.20004814 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.19224661 |
| 57 | MP0005451_abnormal_body_composition | 1.17996492 |
| 58 | MP0005670_abnormal_white_adipose | 1.16557848 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.13583659 |
| 60 | MP0002108_abnormal_muscle_morphology | 1.09165123 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.06574300 |
| 62 | MP0006138_congestive_heart_failure | 1.03751289 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.93764433 |
| 64 | MP0000733_abnormal_muscle_development | 0.92119507 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.92090843 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.87206529 |
| 67 | MP0003879_abnormal_hair_cell | 0.83775398 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.82800990 |
| 69 | MP0003868_abnormal_feces_composition | 0.81115600 |
| 70 | MP0004085_abnormal_heartbeat | 0.81093009 |
| 71 | MP0005334_abnormal_fat_pad | 0.80859856 |
| 72 | MP0000003_abnormal_adipose_tissue | 0.80376484 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 0.80258840 |
| 74 | MP0001764_abnormal_homeostasis | 0.79851393 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.75184789 |
| 76 | MP0003950_abnormal_plasma_membrane | 0.73966862 |
| 77 | MP0009697_abnormal_copulation | 0.72281835 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.71339317 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.68256638 |
| 80 | MP0005535_abnormal_body_temperature | 0.66171833 |
| 81 | MP0003186_abnormal_redox_activity | 0.63228878 |
| 82 | MP0000230_abnormal_systemic_arterial | 0.62966701 |
| 83 | MP0004043_abnormal_pH_regulation | 0.62416008 |
| 84 | MP0000343_altered_response_to | 0.62403120 |
| 85 | MP0004147_increased_porphyrin_level | 0.61763557 |
| 86 | * MP0000598_abnormal_liver_morphology | 0.61253532 |
| 87 | MP0005187_abnormal_penis_morphology | 0.57920655 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.56777031 |
| 89 | MP0003011_delayed_dark_adaptation | 0.55311049 |
| 90 | MP0004510_myositis | 0.54795104 |
| 91 | MP0003828_pulmonary_edema | 0.53919979 |
| 92 | * MP0009642_abnormal_blood_homeostasis | 0.53680723 |
| 93 | MP0002822_catalepsy | 0.52838650 |
| 94 | MP0005165_increased_susceptibility_to | 0.52207674 |
| 95 | MP0003045_fibrosis | 0.51754647 |
| 96 | MP0009763_increased_sensitivity_to | 0.50628212 |
| 97 | * MP0000266_abnormal_heart_morphology | 0.50200355 |
| 98 | MP0009672_abnormal_birth_weight | 0.47230368 |
| 99 | MP0005647_abnormal_sex_gland | 0.45864951 |
| 100 | MP0000372_irregular_coat_pigmentation | 0.45717166 |
| 101 | MP0005166_decreased_susceptibility_to | 0.44857665 |
| 102 | MP0009764_decreased_sensitivity_to | 0.44272234 |
| 103 | MP0002128_abnormal_blood_circulation | 0.43733197 |
| 104 | MP0008469_abnormal_protein_level | 0.42568940 |
| 105 | MP0009115_abnormal_fat_cell | 0.42300307 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.41459120 |
| 107 | MP0004142_abnormal_muscle_tone | 0.40801438 |
| 108 | MP0000604_amyloidosis | 0.40422591 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.40415430 |
| 110 | MP0005448_abnormal_energy_balance | 0.40069590 |
| 111 | MP0004134_abnormal_chest_morphology | 0.39766477 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.39454693 |
| 113 | * MP0005636_abnormal_mineral_homeostasis | 0.38435308 |
| 114 | MP0001853_heart_inflammation | 0.36106963 |
| 115 | MP0000579_abnormal_nail_morphology | 0.35912906 |
| 116 | MP0002249_abnormal_larynx_morphology | 0.35016950 |
| 117 | MP0008874_decreased_physiological_sensi | 0.33610622 |
| 118 | MP0005452_abnormal_adipose_tissue | 0.33593722 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.30526616 |
| 120 | MP0003959_abnormal_lean_body | 0.29198283 |
| 121 | MP0002638_abnormal_pupillary_reflex | 0.26077500 |
| 122 | MP0003948_abnormal_gas_homeostasis | 0.25795515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.80014692 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.26413218 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 6.08040514 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.85181480 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.59753648 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.35811763 |
| 7 | Nemaline bodies (HP:0003798) | 5.35398873 |
| 8 | Myoglobinuria (HP:0002913) | 5.14773029 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 4.56853491 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.35875267 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.29643115 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.26882406 |
| 13 | Distal arthrogryposis (HP:0005684) | 4.23806672 |
| 14 | Rhabdomyolysis (HP:0003201) | 4.20960378 |
| 15 | Difficulty running (HP:0009046) | 4.03469761 |
| 16 | Sudden death (HP:0001699) | 3.88881902 |
| 17 | Myopathic facies (HP:0002058) | 3.80945505 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 3.77375004 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 3.76079300 |
| 20 | Round ear (HP:0100830) | 3.72236981 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.63879209 |
| 22 | Intrahepatic cholestasis (HP:0001406) | 3.63549028 |
| 23 | Increased connective tissue (HP:0009025) | 3.61671880 |
| 24 | Muscle stiffness (HP:0003552) | 3.61390489 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.47125710 |
| 26 | Xanthomatosis (HP:0000991) | 3.40012015 |
| 27 | Ketosis (HP:0001946) | 3.36572834 |
| 28 | Ulnar deviation of the wrist (HP:0003049) | 3.36231596 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.29636986 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.23768467 |
| 31 | Ventricular tachycardia (HP:0004756) | 3.20664114 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 3.20443998 |
| 33 | Myotonia (HP:0002486) | 3.19078780 |
| 34 | Subaortic stenosis (HP:0001682) | 3.16099325 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.16099325 |
| 36 | Hyperammonemia (HP:0001987) | 3.15151559 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.10539454 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 3.07479432 |
| 39 | Ketoacidosis (HP:0001993) | 3.05084260 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.04065709 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 3.02350143 |
| 42 | Absent phalangeal crease (HP:0006109) | 3.01823243 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.89542111 |
| 44 | Prolonged partial thromboplastin time (HP:0003645) | 2.88120692 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79379700 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.74566194 |
| 47 | Hyperglycinuria (HP:0003108) | 2.71587707 |
| 48 | Generalized muscle weakness (HP:0003324) | 2.70197104 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.68976407 |
| 50 | Calcaneovalgus deformity (HP:0001848) | 2.67102820 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.66806760 |
| 52 | Hyperglycinemia (HP:0002154) | 2.66776113 |
| 53 | Cholelithiasis (HP:0001081) | 2.66505903 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.61753185 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.61753185 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.59100211 |
| 57 | Complement deficiency (HP:0004431) | 2.55847664 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.54934367 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53564691 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.52298550 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52298550 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.51859627 |
| 63 | Lipoatrophy (HP:0100578) | 2.51631699 |
| 64 | Bulbar palsy (HP:0001283) | 2.51613990 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50532414 |
| 66 | Cerebral edema (HP:0002181) | 2.48827275 |
| 67 | Gowers sign (HP:0003391) | 2.47682857 |
| 68 | Areflexia of lower limbs (HP:0002522) | 2.46482022 |
| 69 | Abnormal finger flexion creases (HP:0006143) | 2.44791765 |
| 70 | Palpitations (HP:0001962) | 2.42013477 |
| 71 | Abnormality of the calcaneus (HP:0008364) | 2.41604921 |
| 72 | Malignant hyperthermia (HP:0002047) | 2.41008039 |
| 73 | Weak cry (HP:0001612) | 2.40799680 |
| 74 | Deformed tarsal bones (HP:0008119) | 2.40558268 |
| 75 | Rimmed vacuoles (HP:0003805) | 2.35591681 |
| 76 | Dilated cardiomyopathy (HP:0001644) | 2.34736150 |
| 77 | Neck muscle weakness (HP:0000467) | 2.34013222 |
| 78 | Slender build (HP:0001533) | 2.32930521 |
| 79 | Fatigable weakness (HP:0003473) | 2.31579660 |
| 80 | Abnormality of the neuromuscular junction (HP:0003398) | 2.31579660 |
| 81 | Gout (HP:0001997) | 2.31107537 |
| 82 | Limb-girdle muscle atrophy (HP:0003797) | 2.29041902 |
| 83 | Metabolic acidosis (HP:0001942) | 2.27307696 |
| 84 | Epidermoid cyst (HP:0200040) | 2.26570020 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.25093904 |
| 86 | Distal lower limb muscle weakness (HP:0009053) | 2.21098002 |
| 87 | Scapular winging (HP:0003691) | 2.20150140 |
| 88 | Hyperkalemia (HP:0002153) | 2.13865489 |
| 89 | Bundle branch block (HP:0011710) | 2.09858312 |
| 90 | Hepatic necrosis (HP:0002605) | 2.09725275 |
| 91 | Atrial fibrillation (HP:0005110) | 2.09186963 |
| 92 | Hip contracture (HP:0003273) | 2.08770994 |
| 93 | Heart block (HP:0012722) | 2.08463602 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.08074694 |
| 95 | Frequent falls (HP:0002359) | 2.07086384 |
| 96 | Progressive muscle weakness (HP:0003323) | 2.06743025 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05774472 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.03938149 |
| 99 | Joint hemorrhage (HP:0005261) | 2.02860742 |
| 100 | Abnormality of methionine metabolism (HP:0010901) | 2.02497989 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 2.01620928 |
| 102 | Lethargy (HP:0001254) | 2.01396239 |
| 103 | Atrioventricular block (HP:0001678) | 2.01160981 |
| 104 | Hyperglycemia (HP:0003074) | 2.01002707 |
| 105 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99891599 |
| 106 | Spinal rigidity (HP:0003306) | 1.99080849 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 1.98416800 |
| 108 | Increased purine levels (HP:0004368) | 1.96668986 |
| 109 | Hyperuricemia (HP:0002149) | 1.96668986 |
| 110 | Popliteal pterygium (HP:0009756) | 1.96522599 |
| 111 | Increased muscle lipid content (HP:0009058) | 1.95746677 |
| 112 | Acute encephalopathy (HP:0006846) | 1.95374289 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 1.95181008 |
| 114 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.94485302 |
| 115 | Late onset (HP:0003584) | 1.94240915 |
| 116 | Hyperbilirubinemia (HP:0002904) | 1.92934470 |
| 117 | Primary atrial arrhythmia (HP:0001692) | 1.91017469 |
| 118 | Skin nodule (HP:0200036) | 1.90311922 |
| 119 | Abnormality of the Achilles tendon (HP:0005109) | 1.88384353 |
| 120 | Proximal amyotrophy (HP:0007126) | 1.83331319 |
| 121 | Waddling gait (HP:0002515) | 1.83085393 |
| 122 | Muscular dystrophy (HP:0003560) | 1.82993781 |
| 123 | Abnormality of the foot musculature (HP:0001436) | 1.81418362 |
| 124 | Metatarsus adductus (HP:0001840) | 1.79883933 |
| 125 | Long clavicles (HP:0000890) | 1.76044934 |
| 126 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.73904783 |
| 127 | Paralysis (HP:0003470) | 1.70708798 |
| 128 | Ragged-red muscle fibers (HP:0003200) | 1.68845266 |
| 129 | Foot dorsiflexor weakness (HP:0009027) | 1.68766911 |
| 130 | Exercise intolerance (HP:0003546) | 1.68159718 |
| 131 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.68147304 |
| 132 | Lower limb amyotrophy (HP:0007210) | 1.65784830 |
| 133 | Type 2 muscle fiber atrophy (HP:0003554) | 1.63887096 |
| 134 | Nonprogressive disorder (HP:0003680) | 1.60406666 |
| 135 | Limb-girdle muscle weakness (HP:0003325) | 1.53274236 |
| 136 | Abnormality of complement system (HP:0005339) | 1.53073840 |
| 137 | Ulnar deviation of finger (HP:0009465) | 1.49868960 |
| 138 | Muscle fiber atrophy (HP:0100295) | 1.49466038 |
| 139 | Reduced antithrombin III activity (HP:0001976) | 1.48558980 |
| 140 | Ventricular arrhythmia (HP:0004308) | 1.48111120 |
| 141 | Facial diplegia (HP:0001349) | 1.47192891 |
| 142 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.45633607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.17739237 |
| 2 | TTN | 5.86108065 |
| 3 | PHKG2 | 4.51369741 |
| 4 | PHKG1 | 4.51369741 |
| 5 | BCKDK | 4.31229834 |
| 6 | PIK3CG | 2.83446371 |
| 7 | PDK3 | 2.67305423 |
| 8 | PDK4 | 2.67305423 |
| 9 | TRIB3 | 2.64395494 |
| 10 | PINK1 | 2.49511550 |
| 11 | MAP2K3 | 2.31710097 |
| 12 | PKN2 | 2.23528651 |
| 13 | NEK1 | 2.11447440 |
| 14 | NME1 | 2.00130079 |
| 15 | MAP3K7 | 1.97630878 |
| 16 | PIK3CA | 1.81155964 |
| 17 | SIK1 | 1.78879454 |
| 18 | MAP2K4 | 1.73950483 |
| 19 | PDK2 | 1.62426133 |
| 20 | DMPK | 1.61848660 |
| 21 | MAPK12 | 1.56378294 |
| 22 | FGFR4 | 1.54354087 |
| 23 | MUSK | 1.50544039 |
| 24 | ERN1 | 1.41356650 |
| 25 | INSRR | 1.40293132 |
| 26 | NEK9 | 1.20237549 |
| 27 | MYLK | 1.19427890 |
| 28 | PRKAA2 | 1.17800465 |
| 29 | TIE1 | 1.15965737 |
| 30 | LMTK2 | 1.14766662 |
| 31 | MAP2K6 | 1.06122562 |
| 32 | MAPK11 | 1.03180034 |
| 33 | PRKAA1 | 1.02088185 |
| 34 | FLT3 | 0.98585725 |
| 35 | EEF2K | 0.97861813 |
| 36 | MAP3K3 | 0.96417818 |
| 37 | MARK1 | 0.95702759 |
| 38 | STK24 | 0.91607295 |
| 39 | MOS | 0.91352662 |
| 40 | CCNB1 | 0.88416613 |
| 41 | LIMK1 | 0.85015439 |
| 42 | PTK6 | 0.79949207 |
| 43 | EPHB1 | 0.72198481 |
| 44 | CAMK2G | 0.71787877 |
| 45 | RIPK1 | 0.71254993 |
| 46 | MAPKAPK3 | 0.67400821 |
| 47 | LATS1 | 0.66000453 |
| 48 | MAP3K5 | 0.65276941 |
| 49 | PRKD1 | 0.61097772 |
| 50 | ERBB3 | 0.60435325 |
| 51 | STK38L | 0.59750005 |
| 52 | MAP3K11 | 0.58387666 |
| 53 | TYK2 | 0.58187917 |
| 54 | PKN1 | 0.57027578 |
| 55 | ERBB4 | 0.56655099 |
| 56 | MAP3K13 | 0.56414140 |
| 57 | TAOK2 | 0.54578034 |
| 58 | KSR2 | 0.54572250 |
| 59 | KDR | 0.51057287 |
| 60 | PAK3 | 0.50801546 |
| 61 | CAMK2D | 0.50564439 |
| 62 | GRK7 | 0.49670567 |
| 63 | TRPM7 | 0.49077238 |
| 64 | MAP3K10 | 0.46805961 |
| 65 | AKT2 | 0.46449015 |
| 66 | JAK2 | 0.43734515 |
| 67 | TGFBR2 | 0.43659014 |
| 68 | PDPK1 | 0.43293655 |
| 69 | MST1R | 0.42837407 |
| 70 | MAPK4 | 0.42780049 |
| 71 | ILK | 0.42549114 |
| 72 | PRKACG | 0.42199714 |
| 73 | CAMK2B | 0.40340979 |
| 74 | PRKACB | 0.40057269 |
| 75 | CAMK4 | 0.39192023 |
| 76 | ROCK1 | 0.36983133 |
| 77 | ZAK | 0.36657507 |
| 78 | TAOK3 | 0.36311188 |
| 79 | ICK | 0.36296644 |
| 80 | MAPK7 | 0.36026907 |
| 81 | PRPF4B | 0.35615641 |
| 82 | JAK1 | 0.34440161 |
| 83 | CAMK1 | 0.33159309 |
| 84 | ABL2 | 0.33016211 |
| 85 | PDK1 | 0.31177121 |
| 86 | PRKACA | 0.30379979 |
| 87 | RPS6KB1 | 0.29969676 |
| 88 | SGK3 | 0.29361934 |
| 89 | PDGFRA | 0.29133562 |
| 90 | MAP3K1 | 0.27925645 |
| 91 | SGK2 | 0.27340342 |
| 92 | TAOK1 | 0.26123323 |
| 93 | MAP3K6 | 0.25845310 |
| 94 | MAP2K1 | 0.25733024 |
| 95 | MAPK10 | 0.24605830 |
| 96 | TBK1 | 0.24456806 |
| 97 | RPS6KA3 | 0.23824889 |
| 98 | PRKG1 | 0.23274756 |
| 99 | DYRK1B | 0.23190036 |
| 100 | MTOR | 0.22403157 |
| 101 | CAMK2A | 0.22357384 |
| 102 | DAPK2 | 0.22012648 |
| 103 | ARAF | 0.21148405 |
| 104 | STK38 | 0.20981669 |
| 105 | SGK1 | 0.18176087 |
| 106 | LATS2 | 0.17380840 |
| 107 | RET | 0.17081055 |
| 108 | MAPK13 | 0.16911637 |
| 109 | ZAP70 | 0.16544134 |
| 110 | GSK3A | 0.16251803 |
| 111 | RPS6KA1 | 0.15668594 |
| 112 | FGFR3 | 0.15202789 |
| 113 | EPHA3 | 0.13844676 |
| 114 | RPS6KB2 | 0.13798154 |
| 115 | PTK2B | 0.13468000 |
| 116 | PRKCQ | 0.13106027 |
| 117 | SGK494 | 0.12642473 |
| 118 | SGK223 | 0.12642473 |
| 119 | RPS6KL1 | 0.12094620 |
| 120 | RPS6KC1 | 0.12094620 |
| 121 | CAMK1D | 0.11673103 |
| 122 | RAF1 | 0.11219909 |
| 123 | MARK2 | 0.11042946 |
| 124 | CAMK1G | 0.10511672 |
| 125 | TNK2 | 0.09114094 |
| 126 | RPS6KA6 | 0.07926864 |
| 127 | CSNK1D | 0.07899766 |
| 128 | NLK | 0.06553734 |
| 129 | STK11 | 0.05760709 |
| 130 | MAPK3 | 0.04712739 |
| 131 | PRKCA | 0.04317497 |
| 132 | CDK19 | 0.03269794 |
| 133 | MAPK9 | 0.02767668 |
| 134 | MAP2K2 | 0.02659866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.00158298 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.36979998 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.08533797 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.06499162 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.96508292 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.92561775 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.84394127 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.77060247 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70145159 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.66840645 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36128814 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27702467 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26356372 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16036508 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.13303012 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.04276986 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93176755 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91008719 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89583935 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.88502288 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87190667 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.84881448 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66176860 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64161867 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62641536 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58544427 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55067967 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47879549 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47294659 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45209882 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.40625685 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37833294 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33832201 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33301489 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31060322 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26904762 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25685246 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21233130 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20773801 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.17192353 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16944130 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.15520913 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12206439 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06945003 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06612367 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04911263 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04629492 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04121557 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02956879 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98715508 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97459117 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95668729 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95140618 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93678523 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.93007520 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90008838 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.88790132 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.84566924 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83857624 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82478889 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80419177 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73221779 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72176590 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71279485 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69541000 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67599296 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65445304 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65007359 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63850877 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63130533 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62052570 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55284003 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52379995 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51356926 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49150146 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46811716 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40335424 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40065597 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40050800 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39206399 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34952545 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34510737 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34114653 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32390101 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28644917 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28586150 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27548750 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.27540126 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27252803 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23953707 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.22723026 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22156637 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.21892380 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18546801 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14293591 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.14091012 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12114212 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11703817 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.10565189 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10370443 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.10299303 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.10128593 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.08977174 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.08525947 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.06355047 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.05650039 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.05223824 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.04102115 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02313562 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.02070763 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01758488 |
| 112 | Focal adhesion_Homo sapiens_hsa04510 | -0.0571111 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0006949 |

